- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Biosimilars of Rituximab will have significant change from previous year. By the most conservative estimates of global Biosimilars of Rituximab market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Biosimilars of Rituximab market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars of Rituximab market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
500mg
100mg
Other
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital Pharmacy
Retail Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Amgen
AryoGen Pharmed
Biocad
Cadila Pharmaceuticals
Celltrion
Dr Reddy’s Laboratories
Teva
Hetero Group
Innovent Biologics
Intas Biopharmaceuticals
Mylan
Probiomed
TRPharma
Zenotech Laboratories
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilars of Rituximab Consumption 2016-2026
2.1.2 Biosimilars of Rituximab Consumption CAGR by Region
2.2 Biosimilars of Rituximab Segment by Type
2.2.1 500mg
2.2.2 100mg
2.2.3 Other
2.3 Biosimilars of Rituximab Sales by Type
2.3.1 Global Biosimilars of Rituximab Sales Market Share by Type (2016-2021)
2.3.2 Global Biosimilars of Rituximab Revenue and Market Share by Type (2016-2021)
2.3.3 Global Biosimilars of Rituximab Sale Price by Type (2016-2021)
2.4 Biosimilars of Rituximab Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.5 Biosimilars of Rituximab Sales by Application
2.5.1 Global Biosimilars of Rituximab Sale Market Share by Application (2016-2021)
2.5.2 Global Biosimilars of Rituximab Revenue and Market Share by Application (2016-2021)
2.5.3 Global Biosimilars of Rituximab Sale Price by Application (2016-2021)
3 Global Biosimilars of Rituximab by Company
3.1 Global Biosimilars of Rituximab Sales Market Share by Company
3.1.1 Global Biosimilars of Rituximab Sales by Company (2019-2021)
3.1.2 Global Biosimilars of Rituximab Sales Market Share by Company (2019-2021)
3.2 Global Biosimilars of Rituximab Revenue Market Share by Company
3.2.1 Global Biosimilars of Rituximab Revenue by Company (2019-2021)
3.2.2 Global Biosimilars of Rituximab Revenue Market Share by Company (2019-2021)
3.3 Global Biosimilars of Rituximab Sale Price by Company
3.4 Global Manufacturers Biosimilars of Rituximab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biosimilars of Rituximab Product Location Distribution
3.4.2 Players Biosimilars of Rituximab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Biosimilars of Rituximab by Region
4.1 Global Biosimilars of Rituximab by Region
4.1.1 Global Biosimilars of Rituximab Sales by Region
4.1.2 Global Biosimilars of Rituximab Revenue by Region
4.2 Americas Biosimilars of Rituximab Sales Growth
4.3 APAC Biosimilars of Rituximab Sales Growth
4.4 Europe Biosimilars of Rituximab Sales Growth
4.5 Middle East & Africa Biosimilars of Rituximab Sales Growth
5 Americas
5.1 Americas Biosimilars of Rituximab Sales by Country
5.1.1 Americas Biosimilars of Rituximab Sales by Country (2016-2021)
5.1.2 Americas Biosimilars of Rituximab Revenue by Country (2016-2021)
5.2 Americas Biosimilars of Rituximab Sales by Type
5.3 Americas Biosimilars of Rituximab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars of Rituximab Sales by Region
6.1.1 APAC Biosimilars of Rituximab Sales by Region (2016-2021)
6.1.2 APAC Biosimilars of Rituximab Revenue by Region (2016-2021)
6.2 APAC Biosimilars of Rituximab Sales by Type
6.3 APAC Biosimilars of Rituximab Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biosimilars of Rituximab by Country
7.1.1 Europe Biosimilars of Rituximab Sales by Country (2016-2021)
7.1.2 Europe Biosimilars of Rituximab Revenue by Country (2016-2021)
7.2 Europe Biosimilars of Rituximab Sales by Type
7.3 Europe Biosimilars of Rituximab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biosimilars of Rituximab by Country
8.1.1 Middle East & Africa Biosimilars of Rituximab Sales by Country (2016-2021)
8.1.2 Middle East & Africa Biosimilars of Rituximab Revenue by Country (2016-2021)
8.2 Middle East & Africa Biosimilars of Rituximab Sales by Type
8.3 Middle East & Africa Biosimilars of Rituximab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biosimilars of Rituximab Distributors
10.3 Biosimilars of Rituximab Customer
11 Global Biosimilars of Rituximab Market Forecast
11.1 Global Biosimilars of Rituximab Forecast by Region
11.1.1 Global Biosimilars of Rituximab Forecast by Regions (2021-2026)
11.2.2 Global Biosimilars of Rituximab Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Biosimilars of Rituximab Forecast by Type
11.7 Global Biosimilars of Rituximab Forecast by Application
12 Key Players Analysis
12.1 Amgen
12.1.1 Amgen Company Information
12.1.2 Amgen Biosimilars of Rituximab Product Offered
12.1.3 Amgen Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Amgen Main Business Overview
12.1.5 Amgen Latest Developments
12.2 AryoGen Pharmed
12.2.1 AryoGen Pharmed Company Information
12.2.2 AryoGen Pharmed Biosimilars of Rituximab Product Offered
12.2.3 AryoGen Pharmed Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 AryoGen Pharmed Main Business Overview
12.2.5 AryoGen Pharmed Latest Developments
12.3 Biocad
12.3.1 Biocad Company Information
12.3.2 Biocad Biosimilars of Rituximab Product Offered
12.3.3 Biocad Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Biocad Main Business Overview
12.3.5 Biocad Latest Developments
12.4 Cadila Pharmaceuticals
12.4.1 Cadila Pharmaceuticals Company Information
12.4.2 Cadila Pharmaceuticals Biosimilars of Rituximab Product Offered
12.4.3 Cadila Pharmaceuticals Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Cadila Pharmaceuticals Main Business Overview
12.4.5 Cadila Pharmaceuticals Latest Developments
12.5 Celltrion
12.5.1 Celltrion Company Information
12.5.2 Celltrion Biosimilars of Rituximab Product Offered
12.5.3 Celltrion Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Celltrion Main Business Overview
12.5.5 Celltrion Latest Developments
12.6 Dr Reddy’s Laboratories
12.6.1 Dr Reddy’s Laboratories Company Information
12.6.2 Dr Reddy’s Laboratories Biosimilars of Rituximab Product Offered
12.6.3 Dr Reddy’s Laboratories Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Dr Reddy’s Laboratories Main Business Overview
12.6.5 Dr Reddy’s Laboratories Latest Developments
12.7 Teva
12.7.1 Teva Company Information
12.7.2 Teva Biosimilars of Rituximab Product Offered
12.7.3 Teva Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Teva Main Business Overview
12.7.5 Teva Latest Developments
12.8 Hetero Group
12.8.1 Hetero Group Company Information
12.8.2 Hetero Group Biosimilars of Rituximab Product Offered
12.8.3 Hetero Group Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Hetero Group Main Business Overview
12.8.5 Hetero Group Latest Developments
12.9 Innovent Biologics
12.9.1 Innovent Biologics Company Information
12.9.2 Innovent Biologics Biosimilars of Rituximab Product Offered
12.9.3 Innovent Biologics Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Innovent Biologics Main Business Overview
12.9.5 Innovent Biologics Latest Developments
12.10 Intas Biopharmaceuticals
12.10.1 Intas Biopharmaceuticals Company Information
12.10.2 Intas Biopharmaceuticals Biosimilars of Rituximab Product Offered
12.10.3 Intas Biopharmaceuticals Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Intas Biopharmaceuticals Main Business Overview
12.10.5 Intas Biopharmaceuticals Latest Developments
12.11 Mylan
12.11.1 Mylan Company Information
12.11.2 Mylan Biosimilars of Rituximab Product Offered
12.11.3 Mylan Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Mylan Main Business Overview
12.11.5 Mylan Latest Developments
12.12 Probiomed
12.12.1 Probiomed Company Information
12.12.2 Probiomed Biosimilars of Rituximab Product Offered
12.12.3 Probiomed Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Probiomed Main Business Overview
12.12.5 Probiomed Latest Developments
12.13 TRPharma
12.13.1 TRPharma Company Information
12.13.2 TRPharma Biosimilars of Rituximab Product Offered
12.13.3 TRPharma Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 TRPharma Main Business Overview
12.13.5 TRPharma Latest Developments
12.14 Zenotech Laboratories
12.14.1 Zenotech Laboratories Company Information
12.14.2 Zenotech Laboratories Biosimilars of Rituximab Product Offered
12.14.3 Zenotech Laboratories Biosimilars of Rituximab Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Zenotech Laboratories Main Business Overview
12.14.5 Zenotech Laboratories Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Biosimilars of Rituximab Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of 500mg
Table 3. Major Players of 100mg
Table 4. Major Players of Other
Table 5. Global Biosimilars of Rituximab Sales by Type (2016-2021) & (K Units)
Table 6. Global Biosimilars of Rituximab Sales Market Share by Type (2016-2021)
Table 7. Global Biosimilars of Rituximab Revenue by Type (2016-2021) & ($ million)
Table 8. Global Biosimilars of Rituximab Revenue Market Share by Type (2016-2021)
Table 9. Global Biosimilars of Rituximab Sale Price by Type (2016-2021)
Table 10. Global Biosimilars of Rituximab Sales by Application (2016-2021) & (K Units)
Table 11. Global Biosimilars of Rituximab Sales Market Share by Application (2016-2021)
Table 12. Global Biosimilars of Rituximab Value by Application (2016-2021)
Table 13. Global Biosimilars of Rituximab Revenue Market Share by Application (2016-2021)
Table 14. Global Biosimilars of Rituximab Sale Price by Application (2016-2021)
Table 15. Global Biosimilars of Rituximab Sales by Company (2019-2021) & (K Units)
Table 16. Global Biosimilars of Rituximab Sales Market Share by Company (2019-2021)
Table 17. Global Biosimilars of Rituximab Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Biosimilars of Rituximab Revenue Market Share by Company (2019-2021)
Table 19. Global Biosimilars of Rituximab Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Biosimilars of Rituximab Producing Area Distribution and Sales Area
Table 21. Players Biosimilars of Rituximab Products Offered
Table 22. Biosimilars of Rituximab Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Biosimilars of Rituximab Sales by Region (2016-2021) (K Units)
Table 26. Global Biosimilars of Rituximab Sales Market Share by Region (2016-2021)
Table 27. Global Biosimilars of Rituximab Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Biosimilars of Rituximab Revenue Market Share by Region (2016-2021)
Table 29. Americas Biosimilars of Rituximab Sales by Country (2016-2021) & (K Units)
Table 30. Americas Biosimilars of Rituximab Sales Market Share by Country (2016-2021)
Table 31. Americas Biosimilars of Rituximab Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Biosimilars of Rituximab Revenue Market Share by Country (2016-2021)
Table 33. Americas Biosimilars of Rituximab Sales by Type (2016-2021) & (K Units)
Table 34. Americas Biosimilars of Rituximab Sales Market Share by Type (2016-2021)
Table 35. Americas Biosimilars of Rituximab Sales by Application (2016-2021) & (K Units)
Table 36. Americas Biosimilars of Rituximab Sales Market Share by Application (2016-2021)
Table 37. APAC Biosimilars of Rituximab Sales by Region (2016-2021) & (K Units)
Table 38. APAC Biosimilars of Rituximab Sales Market Share by Region (2016-2021)
Table 39. APAC Biosimilars of Rituximab Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Biosimilars of Rituximab Revenue Market Share by Region (2016-2021)
Table 41. APAC Biosimilars of Rituximab Sales by Type (2016-2021) & (K Units)
Table 42. APAC Biosimilars of Rituximab Sales Market Share by Type (2016-2021)
Table 43. APAC Biosimilars of Rituximab Sales by Application (2016-2021) & (K Units)
Table 44. APAC Biosimilars of Rituximab Sales Market Share by Application (2016-2021)
Table 45. Europe Biosimilars of Rituximab Sales by Country (2016-2021) & (K Units)
Table 46. Europe Biosimilars of Rituximab Sales Market Share by Country (2016-2021)
Table 47. Europe Biosimilars of Rituximab Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Biosimilars of Rituximab Revenue Market Share by Country (2016-2021)
Table 49. Europe Biosimilars of Rituximab Sales by Type (2016-2021) & (K Units)
Table 50. Europe Biosimilars of Rituximab Sales Market Share by Type (2016-2021)
Table 51. Europe Biosimilars of Rituximab Sales by Application (2016-2021) & (K Units)
Table 52. Europe Biosimilars of Rituximab Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Biosimilars of Rituximab Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Biosimilars of Rituximab Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Biosimilars of Rituximab Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Biosimilars of Rituximab Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Biosimilars of Rituximab Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Biosimilars of Rituximab
Table 62. Key Application and Potential Industries of Biosimilars of Rituximab
Table 63. Key Challenges of Biosimilars of Rituximab
Table 64. Key Trends of Biosimilars of Rituximab
Table 65. Biosimilars of Rituximab Distributors List
Table 66. Biosimilars of Rituximab Customer List
Table 67. Global Biosimilars of Rituximab Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Biosimilars of Rituximab Consumption Market Forecast by Region
Table 69. Global Biosimilars of Rituximab Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Biosimilars of Rituximab Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Biosimilars of Rituximab Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Biosimilars of Rituximab Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Biosimilars of Rituximab Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Biosimilars of Rituximab Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Biosimilars of Rituximab Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Biosimilars of Rituximab Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Biosimilars of Rituximab Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Biosimilars of Rituximab Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Biosimilars of Rituximab Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Biosimilars of Rituximab Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Biosimilars of Rituximab Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Biosimilars of Rituximab Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Biosimilars of Rituximab Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Biosimilars of Rituximab Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Biosimilars of Rituximab Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Biosimilars of Rituximab Revenue Market Share Forecast by Application (2021-2026)
Table 87. Amgen Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 88. Amgen Biosimilars of Rituximab Product Offered
Table 89. Amgen Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. Amgen Main Business
Table 91. Amgen Latest Developments
Table 92. AryoGen Pharmed Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 93. AryoGen Pharmed Biosimilars of Rituximab Product Offered
Table 94. AryoGen Pharmed Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. AryoGen Pharmed Main Business
Table 96. AryoGen Pharmed Latest Developments
Table 97. Biocad Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 98. Biocad Biosimilars of Rituximab Product Offered
Table 99. Biocad Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Biocad Main Business
Table 101. Biocad Latest Developments
Table 102. Cadila Pharmaceuticals Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 103. Cadila Pharmaceuticals Biosimilars of Rituximab Product Offered
Table 104. Cadila Pharmaceuticals Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Cadila Pharmaceuticals Main Business
Table 106. Cadila Pharmaceuticals Latest Developments
Table 107. Celltrion Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 108. Celltrion Biosimilars of Rituximab Product Offered
Table 109. Celltrion Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Celltrion Main Business
Table 111. Celltrion Latest Developments
Table 112. Dr Reddy’s Laboratories Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 113. Dr Reddy’s Laboratories Biosimilars of Rituximab Product Offered
Table 114. Dr Reddy’s Laboratories Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Dr Reddy’s Laboratories Main Business
Table 116. Dr Reddy’s Laboratories Latest Developments
Table 117. Teva Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 118. Teva Biosimilars of Rituximab Product Offered
Table 119. Teva Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Teva Main Business
Table 121. Teva Latest Developments
Table 122. Hetero Group Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 123. Hetero Group Biosimilars of Rituximab Product Offered
Table 124. Hetero Group Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Hetero Group Main Business
Table 126. Hetero Group Latest Developments
Table 127. Innovent Biologics Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 128. Innovent Biologics Biosimilars of Rituximab Product Offered
Table 129. Innovent Biologics Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Innovent Biologics Main Business
Table 131. Innovent Biologics Latest Developments
Table 132. Intas Biopharmaceuticals Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 133. Intas Biopharmaceuticals Biosimilars of Rituximab Product Offered
Table 134. Intas Biopharmaceuticals Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. Intas Biopharmaceuticals Main Business
Table 136. Intas Biopharmaceuticals Latest Developments
Table 137. Mylan Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 138. Mylan Biosimilars of Rituximab Product Offered
Table 139. Mylan Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. Mylan Main Business
Table 141. Mylan Latest Developments
Table 142. Probiomed Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 143. Probiomed Biosimilars of Rituximab Product Offered
Table 144. Probiomed Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Probiomed Main Business
Table 146. Probiomed Latest Developments
Table 147. TRPharma Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 148. TRPharma Biosimilars of Rituximab Product Offered
Table 149. TRPharma Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 150. TRPharma Main Business
Table 151. TRPharma Latest Developments
Table 152. Zenotech Laboratories Basic Information, Biosimilars of Rituximab Manufacturing Base, Sales Area and Its Competitors
Table 153. Zenotech Laboratories Biosimilars of Rituximab Product Offered
Table 154. Zenotech Laboratories Biosimilars of Rituximab Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 155. Zenotech Laboratories Main Business
Table 156. Zenotech Laboratories Latest Developments
List of Figures
Figure 1. Picture of Biosimilars of Rituximab
Figure 2. Biosimilars of Rituximab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biosimilars of Rituximab Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Biosimilars of Rituximab Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Biosimilars of Rituximab Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of 500mg
Figure 10. Product Picture of 100mg
Figure 11. Product Picture of Other
Figure 12. Global Biosimilars of Rituximab Sales Market Share by Type in 2020
Figure 13. Global Biosimilars of Rituximab Revenue Market Share by Type (2016-2021)
Figure 14. Biosimilars of Rituximab Consumed in Hospital Pharmacy
Figure 15. Global Biosimilars of Rituximab Market: Hospital Pharmacy (2016-2021) & (K Units)
Figure 16. Biosimilars of Rituximab Consumed in Retail Pharmacy
Figure 17. Global Biosimilars of Rituximab Market: Retail Pharmacy (2016-2021) & (K Units)
Figure 18. Global Biosimilars of Rituximab Sales Market Share by Application (2016-2021)
Figure 19. Global Biosimilars of Rituximab Revenue Market Share by Application in 2020
Figure 20. Biosimilars of Rituximab Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Biosimilars of Rituximab Revenue Market Share by Company in 2020
Figure 22. Global Biosimilars of Rituximab Sales Market Share by Regions (2016-2021)
Figure 23. Global Biosimilars of Rituximab Revenue Market Share by Region in 2020
Figure 24. Americas Biosimilars of Rituximab Sales 2016-2021 (K Units)
Figure 25. Americas Biosimilars of Rituximab Revenue 2016-2021 ($ Millions)
Figure 26. APAC Biosimilars of Rituximab Sales 2016-2021 (K Units)
Figure 27. APAC Biosimilars of Rituximab Revenue 2016-2021 ($ Millions)
Figure 28. Europe Biosimilars of Rituximab Sales 2016-2021 (K Units)
Figure 29. Europe Biosimilars of Rituximab Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Biosimilars of Rituximab Sales 2016-2021 (K Units)
Figure 31. Middle East & Africa Biosimilars of Rituximab Revenue 2016-2021 ($ Millions)
Figure 32. Americas Biosimilars of Rituximab Sales Market Share by Country in 2020
Figure 33. Americas Biosimilars of Rituximab Revenue Market Share by Country in 2020
Figure 34. Americas Biosimilars of Rituximab Sales Market Share by Type in 2020
Figure 35. Americas Biosimilars of Rituximab Sales Market Share by Application in 2020
Figure 36. United States Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Biosimilars of Rituximab Sales Market Share by Region in 2020
Figure 41. APAC Biosimilars of Rituximab Revenue Market Share by Regions in 2020
Figure 42. APAC Biosimilars of Rituximab Sales Market Share by Type in 2020
Figure 43. APAC Biosimilars of Rituximab Sales Market Share by Application in 2020
Figure 44. China Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Biosimilars of Rituximab Sales Market Share by Country in 2020
Figure 51. Europe Biosimilars of Rituximab Revenue Market Share by Country in 2020
Figure 52. Europe Biosimilars of Rituximab Sales Market Share by Type in 2020
Figure 53. Europe Biosimilars of Rituximab Sales Market Share by Application in 2020
Figure 54. Germany Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Biosimilars of Rituximab Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Biosimilars of Rituximab Sales Market Share by Application in 2020
Figure 63. Egypt Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Biosimilars of Rituximab Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
